Skip to content

Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy

Cerebral Hyperemia During Emergence From General Anesthesia for Craniotomy of Patients With Brain Tumor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01642147
Enrollment
60
Registered
2012-07-17
Start date
2012-11-30
Completion date
2013-01-31
Last updated
2013-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Neoplasms, Surgery, Hyperemia

Keywords

Cerebral blood flow, Transcranial Doppler, Emergence from general anesthesia

Brief summary

Few studies look into cerebral blood flow (CBF) changes during emergence from general anesthesia for craniotomy. The purpose of this study is to demonstrate CBF changes during emergence from general anesthesia for craniotomy, through monitoring blood oxygen saturation of jugular vein bulb and transcranial Doppler.

Detailed description

30 patients undergoing selective craniotomy (craniotomy group) for supratentorial brain tumor removal and 30 patients undergoing selective abdominal surgery (abdominal surgery group) are planned to be enrolled in the study. Mean blood flow velocity in middle cerebral artery (Vmca), mean arterial pressure (MAP), blood oxygen saturation of jugular vein bulb (SjvO2) (only measured in craniotomy group)and arterial CO2 partial pressure (PaCO2) will be measured before general anesthesia, at tracheal extubation, and 30,60, 90, 120 min after extubation in both groups.

Interventions

A 2-MHz Transcranial Doppler probe (MULTI-DOP P2.2C; DWL, Elektronische Systeme GmbH, Germany) will be used to measure both sides of Vmca of both patients undergoing craniotomy and patients undergoing abdominal surgery. The signal will be range-gated to a depth of 45 to 60 mm at temporal bone window to achieve the optimal signal according to standard techniques. The measures will be recorded in the operation room before anesthesia, in the recovery room at extubation, 30, 60, 90, and 120 min after extubation.

PROCEDUREjugular venous bulb catheterization

After local anesthesia, a jugular venous bulb catheter(16G, manufactured by Arrow International Inc. USA) will be placed in the dominant side. The proper placement of the tip of the catheter in the jugular bulb will be confirmed later by a postoperative lateral skull X-ray. SjvO2 (blood sample will be drawn slowly at a speed of 2ml per minute) will be measured before anesthesia, at extubation, 30, 60, 90, and 120 min after extubation.

PROCEDURETumor removal surgery under general anesthesia

Surgery types include total or subtotal removal of tumors.For all surgical procedures, general anesthesia will be maintained with isoflurane (0.5-1.0 minimal alveolar concentration (MAC) expired), repeated boluses of fentanyl (1\ 2 µg/kg IV), and continuous vecuronium 50~70 IV. All patients will be mechanical ventilated with oxygen. During anesthesia, blood pressure and heart rate will be kept stable, within ±10% of the preoperative levels. Hematocrit (Hct) will be maintained higher than 30%. After surgery, tracheal extubation will be performed when patients regain full muscle strength, breathe spontaneously with acceptable oxygenation and normocapnia.

After local anesthesia, an intra-arterial pressure line(I.V. catheter and pressure line kit are both manufactured by Smiths Medical International Ltd. USA) will be inserted in radial artery. Sample blood will be drawn from the line before anesthesia, at tracheal extubation, and 30, 60, 90, 120 min after tracheal extubation.

PROCEDUREAbdominal surgery under general anesthesia

For all surgical procedures, general anesthesia will be maintained with isoflurane (0.5-1.0 minimal alveolar concentration (MAC) expired), repeated boluses of fentanyl (1\ 2 µg/kg IV), and continuous vecuronium 50~70 IV. All patients will be mechanical ventilated with oxygen. During anesthesia, blood pressure and heart rate will be kept stable, within ±10% of the preoperative levels. Hematocrit (Hct) will be maintained higher than 30%. After surgery, tracheal extubation will be performed when patients regain full muscle strength, breathe spontaneously with acceptable oxygenation and normocapnia.

Sponsors

Huashan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesia (ASA) physical status I or II * Scheduled for selective supratentorial tumor removal surgery or major abdominal surgery.

Exclusion criteria

* Patients with evidence of systemic hypertension, intracranial hypertension, cerebrovascular diseases, other coexisting medical conditions likely to affect cerebral autoregulation. * Preoperatively planned delayed tracheal extubation. * Pregnant or nursing women

Design outcomes

Primary

MeasureTime frameDescription
Mean Blood Flow Velocity in Middle Cerebral Arterybefore general anesthesiaIt was the baseline mean blood flow velocity in middle cerebral artery.
Oxygen Saturation of Jugular Venous Bulbbefore general anesthesia

Countries

China

Participant flow

Recruitment details

Recruitment period: 11.01.2012-01.31.2013 Study location: Huashan Hospital Fudan University Location Type: Medical centre affiliated to medical university

Pre-assignment details

Transcranial doppler (TCD) and head CT-scan was used to exclude patients with intracranial hypertension,cerebrovascular diseases, or metastatic brain tumor.

Participants by arm

ArmCount
Abdominal Surgery Group
Randomly chosen patients undergoing selective abdominal surgery. Transcranial Doppler measures,radial artery catheterization, and abdominal surgery under general anesthesia will be performed.
30
Craniotomy Group
Patients who are scheduled for selective supratentorial tumor removal surgery will be randomly chosen and recruited. Transcranial Doppler (TCD) measures,jugular venous bulb catheterization, radial artery catheterization, and tumor removal surgery under general anesthesia will be performed.
30
Total60

Baseline characteristics

CharacteristicAbdominal Surgery GroupCraniotomy GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants30 Participants60 Participants
Age Continuous46.6 years
STANDARD_DEVIATION 8.2
47.3 years
STANDARD_DEVIATION 7.6
47.0 years
STANDARD_DEVIATION 7.9
Duration of Surgery207 minute
STANDARD_DEVIATION 49
214 minute
STANDARD_DEVIATION 38
211 minute
STANDARD_DEVIATION 43
Region of Enrollment
China
30 participants30 participants60 participants
Sex: Female, Male
Female
14 Participants13 Participants27 Participants
Sex: Female, Male
Male
16 Participants17 Participants33 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Mean Blood Flow Velocity in Middle Cerebral Artery

It was the baseline mean blood flow velocity in middle cerebral artery.

Time frame: before general anesthesia

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupMean Blood Flow Velocity in Middle Cerebral Artery63.7 cm/sStandard Deviation 6.7
Abdominal Surgery GroupMean Blood Flow Velocity in Middle Cerebral Artery61.8 cm/sStandard Deviation 8.1
Comparison: H0: Mean Blood Flow Velocity in Middle Cerebral Artery of the 2 groups are the same before anesthesia.~Power calculation: beta=0.2, alpha=0.05, two-tailedp-value: 0.554Wilcoxon (Mann-Whitney)
Primary

Mean Blood Flow Velocity in Middle Cerebral Artery

Time frame: after surgery at extubation (average surgery duration: craniotomy group 214min, abdominal group 207min)

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupMean Blood Flow Velocity in Middle Cerebral Artery95.7 cm/sStandard Deviation 16.9
Abdominal Surgery GroupMean Blood Flow Velocity in Middle Cerebral Artery63.6 cm/sStandard Deviation 7.7
Comparison: H0: Mean Blood Flow Velocity in Middle Cerebral Artery of the 2 groups are the same at extubation.~Power calculation: beta=0.2, alpha=0.05, two-tailedp-value: <0.001Wilcoxon (Mann-Whitney)
Primary

Mean Blood Flow Velocity in Middle Cerebral Artery

Time frame: 30min after extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupMean Blood Flow Velocity in Middle Cerebral Artery82.5 cm/sStandard Deviation 12
Abdominal Surgery GroupMean Blood Flow Velocity in Middle Cerebral Artery62.0 cm/sStandard Deviation 8
Comparison: H0: mean blood flow velocity in middle cerebral artery of the 2 groups are the same 30min after extubation.~Power calculation: beta=0.2, alpha=0.05, two-tailedp-value: <0.001Wilcoxon (Mann-Whitney)
Primary

Mean Blood Flow Velocity in Middle Cerebral Artery

Time frame: 60min after extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupMean Blood Flow Velocity in Middle Cerebral Artery77.0 cm/sStandard Deviation 12.1
Abdominal Surgery GroupMean Blood Flow Velocity in Middle Cerebral Artery61.2 cm/sStandard Deviation 7.9
Comparison: H0: mean blood flow velocity in middle cerebral artery of the 2 groups are the same 60min after extubation.~Power calculation: beta=0.2, alpha=0.05, two-tailedp-value: <0.001Wilcoxon (Mann-Whitney)
Primary

Mean Blood Flow Velocity in Middle Cerebral Artery

Time frame: 90min after extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupMean Blood Flow Velocity in Middle Cerebral Artery72.8 cm/sStandard Deviation 11
Abdominal Surgery GroupMean Blood Flow Velocity in Middle Cerebral Artery60.1 cm/sStandard Deviation 8
Comparison: H0: mean blood flow velocity in middle cerebral artery of the 2 groups are the same 90min after extubation.~Power calculation: beta=0.2, alpha=0.05, two-tailedp-value: <0.001Wilcoxon (Mann-Whitney)
Primary

Mean Blood Flow Velocity in Middle Cerebral Artery

Time frame: 120min after extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupMean Blood Flow Velocity in Middle Cerebral Artery69.7 cm/sStandard Deviation 9
Abdominal Surgery GroupMean Blood Flow Velocity in Middle Cerebral Artery59.2 cm/sStandard Deviation 7.8
Comparison: H0: mean blood flow velocity in middle cerebral artery of the 2 groups are the same 120min after extubation.~Power calculation: beta=0.2, alpha=0.05, two-tailedp-value: <0.001Wilcoxon (Mann-Whitney)
Primary

Oxygen Saturation of Jugular Venous Bulb

Time frame: before general anesthesia

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupOxygen Saturation of Jugular Venous Bulb60.9 percentage of oxygen saturationStandard Deviation 3.7
Primary

Oxygen Saturation of Jugular Venous Bulb

Time frame: at extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupOxygen Saturation of Jugular Venous Bulb81.4 percentage of oxygen saturationStandard Deviation 7.4
Primary

Oxygen Saturation of Jugular Venous Bulb

Time frame: 30min after extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupOxygen Saturation of Jugular Venous Bulb77.0 percentage of oxygen saturationStandard Deviation 6.4
Primary

Oxygen Saturation of Jugular Venous Bulb

Time frame: 60min after extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupOxygen Saturation of Jugular Venous Bulb71.8 percentage of oxygen saturationStandard Deviation 6.5
Primary

Oxygen Saturation of Jugular Venous Bulb

Time frame: 90min after extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupOxygen Saturation of Jugular Venous Bulb68.8 percentage of oxygen saturationStandard Deviation 6.4
Primary

Oxygen Saturation of Jugular Venous Bulb

Time frame: 120min after extubation

Population: The number of participants for analysis was determined by sample estimation equation of cohort study. In the equation, the hyperemia frequency from literature and pre-study was used.

ArmMeasureValue (MEAN)Dispersion
Craniotomy GroupOxygen Saturation of Jugular Venous Bulb66.9 percentage of oxygen saturationStandard Deviation 5.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026